JPMorgan Chase & Co’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-29,713	Closed	-$269K	–	3771
2013 Q4	$269K	Buy	29,713 +9,312	+46%	+$84.3K	﹤0.01%	3405
2013 Q3	$129K	Sell	20,401 -3,970	-16%	-$25.1K	﹤0.01%	3737
2013 Q2	$167K	Buy	+24,371	New	+$167K	﹤0.01%	3585